WAYNE, PA — Teleflex Incorporated (NYSE: TFX) has secured two new group purchasing agreements with Premier, Inc. These agreements, effective July 1, 2024, allow Premier members to access special pricing and terms for Teleflex’s hemostatic products.
The Premier National Hemostasis Products and SURPASS® Hemostasis Products agreements are designed to offer high savings for Premier members through aggregated purchasing. The SURPASS® program, in particular, seeks to foster the highest level of commitment and standardization across member facilities, resulting in best-in-market pricing for high-quality products.
Teleflex’s QuikClot™ Hemostatic Dressings and Devices are central to these agreements. These products control bleeding faster than standard gauze or laparotomy pads, allowing clinicians to quickly move patients to the next stage of care. The QuikClot™ portfolio supports various hospital departments, including the Emergency Department, Operating Room, Intensive Care Unit, and Catheterization Lab.
“QuikClot™ Hemostatic Dressings and the QuikClot Control+™ Hemostatic Device are critical tools to aid bleeding control and the blood loss mitigation efforts of acute care clinicians,” said Kevin Robinson, President and General Manager, Anesthesia and Emergency Medicine at Teleflex. “We are pleased to support Premier members with these new Hemostasis product agreements and provide clinicians with medical devices that help improve the health and quality of people’s lives.”
These agreements bolster Teleflex’s commitment to advancing healthcare by equipping clinicians with effective tools for bleeding control, thereby enhancing patient care and outcomes.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.